Scientists can now measure what they might have missed in their cell-based assays.
The new Promega Rapid Response™ Reporter Vectors reduce the risk of secondary effects
and allow measurement of smaller and more transient changes in transcription compared
to their predecessors.
The Rapid Response Reporter Vectors contain degradation sequences that yield a
dramatic improvement in the temporal coupling between transcription and reporter signal.
The relative magnitude of reporter response is also greater.
The combined effect produces higher fold-changes in less time,
enabling researchers to reduce assay times by up to 75%.
The Rapid Response Reporters are available in firefly or Renilla luciferase
configurations and are compatible with a wide range of Promega luminescent
detection reagents. Primary uses include quantitative cellular analysis and
functional genomics applications.
For more information on the Rapid Response Reporter Vectors and other
Promega products, please visit us at our website:
www.promega.com
About Promega
Promega Corporation is a global leader in providing innovative solutions
and technical support for the life sciences industry. The company’s 1,450 products enable scientists worldwide to advance knowledge in genomics,
proteomics, cellular analysis, molecular diagnostics and human
identification. Founded in 1978, the company is headquartered in Madison,
Wisconsin with branches in nine countries and over 50 distributors
throughout the world. Annual sales exceed $150 million.
Rapid Response is a trademark of Promega Corporation.
| 